Checkpoint Inhibitors in Malignant Pleural Mesothelioma
0 Visninger
• 07/02/23
0
0
Indlejre
administrator
Abonnenter
Mark Socinski, MD; Mary Jo Fidler, MD; Roy Herbst, MD, PhD; Geoffrey Oxnard, MD; and Naiyer Rizvi, MD discuss the potential for checkpoint inhibitors, such as pembrolizumab, for malignant mesothelioma. Also discussed is the importance of trials that can be done in the community setting.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer